Investigation into conolidine has triggered discovery of an opioid receptor in the human body identified as ACKR3/CXCR7. ACKR3 appears to be one of the most desired target for conolidine, which also disregards the other four classical opioid receptors(3). This is certainly emerging like a promising alternative drug. Additional importantly, https://ellenu031rvx8.slypage.com/profile